| Screening-based and risk-based strategy for the prevention of early-onset group B streptococcus/non-group B streptococcus sepsis in the neonate: a systematic review and meta … Q Li, D Wang, H Li, J Liu The Pediatric Infectious Disease Journal 39 (8), 740-748, 2020 | 9 | 2020 |
| Evaluation of a beneficial effect of adjuvant chemotherapy in patients with stage I triple-negative breast cancer: a population-based study using the SEER 18 database ZL Du, Y Wang, DY Wang, L Zhang, ZM Bian, Y Deng, CS Xu, DC Lin, ... Breast Cancer Research and Treatment 183, 429-438, 2020 | 8 | 2020 |
| A novel non-invasive exhaled breath biopsy for the diagnosis and screening of breast cancer J Liu, H Chen, Y Li, Y Fang, Y Guo, S Li, J Xu, Z Jia, J Zou, G Liu, H Xu, ... Journal of Hematology & Oncology 16 (1), 63, 2023 | 6 | 2023 |
| Clinicopathologic characteristics and prognostic significance of HER2-low expression in patients with early breast cancer: A systematic review and meta-analysis T Wei, D Wang, S Gao, X Wang, J Yue, Y Kang, J Ju, Z Yang, Y Shuai, ... Frontiers in Oncology 13, 1100332, 2023 | 6 | 2023 |
| Prognostic factors of primary neuroendocrine breast cancer: A population‐based study S Ma, D Wang, Y Liu, H Tan, Y Ge, Y Chi, B Zhang Cancer Medicine 11 (13), 2533-2540, 2022 | 5 | 2022 |
| The role of trastuzumab deruxtecan (T-DXd) in HER2-low metastatic breast cancer treatment T Wei, D Wang, P Yuan Annals of Oncology 34 (10), 948-949, 2023 | 2 | 2023 |
| Predictive Value of the Neutrophil-Lymphocyte Ratio for Tumor Regression Grade and Prognosis of Local Advanced Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy S Li, D Wang, R Wei, G Yu, X Wang, Z Jiang Technology in Cancer Research & Treatment 22, 15330338231202611, 2023 | 1 | 2023 |
| Prognostic factors and adjuvant systemic therapy for patients with HER2-positive T1N0 breast cancer: evidence from a real-world study with long-term follow-up S Gao, D Wang, X Wang, B Zhang, F Du, J Ju, J Yue, Y Kang, X Wang, ... Breast Cancer Research and Treatment 197 (3), 569-582, 2023 | 1 | 2023 |
| Prognostic Value of Copy Number Alteration Burden in Early-Stage Breast Cancer and the Construction of an 11-Gene Copy Number Alteration Model D Wang, S Gao, H Qian, P Yuan, B Zhang Cancers 14 (17), 4145, 2022 | 1 | 2022 |
| Efficacy and safety of epirubicin combined with temozolomide for treatment of advanced leiomyosarcoma H Tan, L Zuo, S Ma, D Wang, R Li, Y Yang, W Liu, Y Chi Cancer Management and Research, 9075-9083, 2021 | 1 | 2021 |
| Prognosis prediction and risk stratification of breast cancer patients based on a mitochondria-related gene signature Y Wang, D Wang, K Bu, J Gao, B Zhang Scientific Reports 14 (1), 2859, 2024 | | 2024 |
| Evaluation of the predictive effect of PD-L1 expression on survival in early triple-negative breast cancer J Yue, X Wang, AJ Zhu, DY Wang, SL Gao, NL Hu, YR Si, FC Zheng, J Ju, ... Zhonghua Zhong liu za zhi [Chinese Journal of Oncology] 45 (11), 948-954, 2023 | | 2023 |
| Differences in clinical characteristics and prognosis between breast neuroendocrine carcinoma and breast invasive ductal carcinoma: A multicentre population‐based study from China D Wang, S Li, S Gao, P Yuan, B Zhang Cancer Medicine 12 (8), 9644-9649, 2023 | | 2023 |
| Analysis of prognostic factors and survival outcomes for patients with T1N0 HER2-positive infiltrating ductal carcinoma of the breast: A real-world study with long-term follow-up. S Gao, D Wang, X Wang, B Xu, P Yuan, B Zhang Journal of Clinical Oncology 40 (16_suppl), e12530-e12530, 2022 | | 2022 |
| Patients with Lung Cancer Followed by Breast Cancer Have a Better Prognosis than Patients with these Cancers in the Opposite Order due to Differences in Pathological Components L Zhang, D Wang, Y Wang, J Ma, Y Wang, B Zhang Eurasian Journal of Medicine and Oncology 5 (2), 187-194, 2021 | | 2021 |
